BeiGene Ltd ADR buy Royal Bank of Canada
Start price
12.09.23
/
50%
€191.00
Target price
12.09.24
€241.54
Performance (%)
-6.28%
End price
13.09.24
€179.00
Summary
This prediction ended on 13.09.24 with a price of €179.00. With a performance of -6.28%, the BUY prediction by Royal_Bank_of_Canada finished with a loss. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BeiGene Ltd ADR | 5.147% | 5.147% | 13.492% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread BeiGene Ltd ADR diskutieren
BeiGene, Ltd. (NASDAQ: BGNE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $259.00 price target on the stock.
Ratings data for BGNE provided by MarketBeat
In the thread Trading BeiGene Ltd ADR
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten